In this recorded panel discussion, members of different healthcare organizations discuss the potential impact of the FDA Rule on LDTs, near term / long term implications, and stakeholder’s priorities for minimal disruption. By watching this panel discussion, you will:
- Gain an understanding of the FDA’s Rule on LDTs, its purpose, significance and impact on the testing industry;
- Understand how certain organizations are managing this, some high level near term and long-term strategies;
- Become familiar with the core concepts, impact on their organization type, and understanding of evolving regulatory landscape.